Activity ID
4646Expires
March 8, 2026Format Type
EnduringCME Credit
1Fee
$150CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)
Description of CME Course
Prescriptions for proton pump inhibitors (PPIs) for infants and children have risen steeply and disproportionately to the incidence of severe cases, such as GERD with erosive esophagitis, for which they are intended. Pediatricians and other pediatric healthcare professionals should be aware of randomized controlled studies demonstrating that PPIs have no effect on uncomplicated gastroesophageal reflux symptoms. New evidence is emerging linking bone deficiency and an increased incidence of fractures in children who were prescribed PPIs in infancy. This activity will review the evidence, the AAP and AAFP guidelines, and recommendations on how to educate parents and manage infants with reflux symptoms.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Family Medicine
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
• Discuss the difference between GER and GERD with parents as explained in the practice guidelines of the AAP or AAFP.
• Diagnose GER or GERD in an infant from history and physical examination.
• Explain the rationale for avoiding the use of PPIs in healthy infants experiencing the symptoms of uncomplicated gastroesophageal reflux.
• Offer multiple techniques for managing symptoms of uncomplicated reflux and crying in infants.
Keywords
PPI, Proton Pump Inhibitors, Colic, Pediatrics
Competencies
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Professionalism
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
